External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Neuroscience AMCP 2025
Roche and Genentech at

AMCP 2025

March 31 - April 03
TX, USA
amcp.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
04:30 PM
Duration 180mins TX, USA
IS UTILIZATION OF COPAY ASSISTANCE CORRELATED WITH LIST AND NET PRICES OF MEDICINES?
Thomas Majda, Danny Sheinson, Rongrong Wang, Anna Hung, William B. Wong
HealthTech

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 180mins TX, USA
IMPACT OF SELF-FUNDED VERSUS FULLY INSURED COMMERCIAL HEALTH PLANS ON DRUG PATIENT LIABILITY
Danny Sheinson, Zhiyu Xia, Stacey Kowal, William B. Wong
HealthTech

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 90mins TX, USA
Muscle MRI outcomes in patients with Duchenne Muscular Dystrophy treated with delandistrogene moxeparvovec: Findings from EMBARK Part 1
Krista Vandenborne, Glenn Walter, Volker Straub, Rebecca Willcocks, Sean Forbes, Sravya Ennamuri, Kai Ding, Carol Reid, Alexander P. Murphy, Marianna Manfrini, Jacob S. Elkins, Louise R. Rodino-Klapac
Neuroscience | Duchenne Muscular Dystrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 90mins TX, USA
Cardiac MRI Outcomes in Patients with Duchenne Muscular Dystrophy Treated with Delandistrogene Moxeparvovec: Findings from EMBARK Part 1
Glenn Walter, Krista Vandenborne, John Bourke, Jonathan Soslow, Stefanie Mason, Emanuel Palatinsky, Christoph Wandel, Kai Ding, Carol Reid, Alexander P. Murphy, Marianna Manfrini, James Richardson, Jacob S. Elkins
Neuroscience | Duchenne Muscular Dystrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
06:00 PM
Duration 180mins TX, USA
Treatment Patterns Among Medicare Advantage Plan Beneficiaries Diagnosed with Neovascular Age-Related Macular Degeneration Who Initiated Faricimab▼ Treatment
Ko S, Tabano D, Saundankar V, Sheer R, Suehs B, Bonine N
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 180mins TX, USA
Treatment Patterns Among Medicare Advantage Plan Beneficiaries Diagnosed with Diabetic Macular Edema Who Initiated Faricimab▼ Treatment
Ko S, Tabano D, Saundankar V, Sheer R, Suehs B, Bonine N
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.